Current risk for transfusion transmitted infections
- PMID: 17898573
- DOI: 10.1097/MOH.0b013e3282e38e8a
Current risk for transfusion transmitted infections
Abstract
Purpose of review: Blood safety is a topic of continuing concern, and much effort is expended on measures to decrease the risk for transmission of infectious agents via transfusion. At the same time, emerging infections may threaten this safety. A periodic review of risk is therefore appropriate.
Recent findings: The risk for major transfusion transmissible infections continues to decline as a result of continually strengthening interventions and because of more general improvements in public health. More attention is being paid to emerging infections, and recently donor testing has been implemented for West Nile virus and Trypanosoma cruzi. Within the period covered by this review, the transmission of variant Creutzfeldt-Jakob disease by transfusion has been confirmed. Our understanding of other agents is improving.
Summary: The estimated risk for transfusion transmitted hepatitis viruses and retroviruses is now vanishingly small, but clinicians should be alert to the possibility of infection with emerging infectious agents, because preventive measures may not be available in all cases.
Similar articles
-
Vector-borne illnesses and the safety of the blood supply.Curr Hematol Rep. 2003 Nov;2(6):511-7. Curr Hematol Rep. 2003. PMID: 14561396 Review.
-
Transfusion-transmitted diseases other than AIDS and hepatitis.Yale J Biol Med. 1990 Sep-Oct;63(5):347-51. Yale J Biol Med. 1990. PMID: 1963503 Free PMC article. Review.
-
European strategies against the parasite transfusion risk.Transfus Clin Biol. 2005 Feb;12(1):1-4. doi: 10.1016/j.tracli.2004.12.001. Transfus Clin Biol. 2005. PMID: 15814284
-
Current risks in blood transfusion in Japan.Jpn J Infect Dis. 2008 Nov;61(6):427-33. Jpn J Infect Dis. 2008. PMID: 19050347 Review.
-
Reacting to an emerging safety threat: West Nile virus in North America.Dev Biol (Basel). 2007;127:43-58. Dev Biol (Basel). 2007. PMID: 17486880
Cited by
-
Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?Transfusion. 2012 Jul;52(7):1398-403. doi: 10.1111/j.1537-2995.2012.03721.x. Transfusion. 2012. PMID: 22780892 Free PMC article. No abstract available.
-
Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.Transfus Med Rev. 2010 Apr;24(2):77-124. doi: 10.1016/j.tmrv.2009.11.001. Transfus Med Rev. 2010. PMID: 20303034 Free PMC article. Review.
-
Blood Donor Deferrals for Malaria in Iran: A Five-Year Retrospective Study.Iran J Parasitol. 2019 Apr-Jun;14(2):326-333. Iran J Parasitol. 2019. PMID: 31543922 Free PMC article.
-
Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.Biotechnol J. 2009 Feb;4(2):186-201. doi: 10.1002/biot.200800241. Biotechnol J. 2009. PMID: 19226552 Free PMC article. Review.
-
Improvement of blood transfusion safety using the chemiluminescence technique for viral marker screening of blood donors in sub Saharan Africa.Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S72-S79. doi: 10.1016/j.htct.2024.04.120. Epub 2024 Sep 7. Hematol Transfus Cell Ther. 2024. PMID: 39317575 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials